191 related articles for article (PubMed ID: 33506526)
1. Intranasal insulin.
Hallschmid M
J Neuroendocrinol; 2021 Apr; 33(4):e12934. PubMed ID: 33506526
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Insulin for Alzheimer's Disease.
Hallschmid M
CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
[TBL] [Abstract][Full Text] [Related]
3. Targeting metabolic and cognitive pathways of the CNS by intranasal insulin administration.
Hallschmid M; Benedict C; Born J; Kern W
Expert Opin Drug Deliv; 2007 Jul; 4(4):319-22. PubMed ID: 17683246
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and clinical implications of intranasal insulin administration to the central nervous system.
Santiago JCP; Hallschmid M
Exp Neurol; 2019 Jul; 317():180-190. PubMed ID: 30885653
[TBL] [Abstract][Full Text] [Related]
5. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.
Freiherr J; Hallschmid M; Frey WH; Brünner YF; Chapman CD; Hölscher C; Craft S; De Felice FG; Benedict C
CNS Drugs; 2013 Jul; 27(7):505-14. PubMed ID: 23719722
[TBL] [Abstract][Full Text] [Related]
6. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism.
Ott V; Benedict C; Schultes B; Born J; Hallschmid M
Diabetes Obes Metab; 2012 Mar; 14(3):214-21. PubMed ID: 21883804
[TBL] [Abstract][Full Text] [Related]
7. Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans.
Stockhorst U; de Fries D; Steingrueber HJ; Scherbaum WA
Physiol Behav; 2004 Oct; 83(1):47-54. PubMed ID: 15501490
[TBL] [Abstract][Full Text] [Related]
8. Obese men respond to cognitive but not to catabolic brain insulin signaling.
Hallschmid M; Benedict C; Schultes B; Born J; Kern W
Int J Obes (Lond); 2008 Feb; 32(2):275-82. PubMed ID: 17848936
[TBL] [Abstract][Full Text] [Related]
9. Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition.
Salameh TS; Bullock KM; Hujoel IA; Niehoff ML; Wolden-Hanson T; Kim J; Morley JE; Farr SA; Banks WA
J Alzheimers Dis; 2015; 47(3):715-28. PubMed ID: 26401706
[TBL] [Abstract][Full Text] [Related]
10. Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans.
Jauch-Chara K; Friedrich A; Rezmer M; Melchert UH; G Scholand-Engler H; Hallschmid M; Oltmanns KM
Diabetes; 2012 Sep; 61(9):2261-8. PubMed ID: 22586589
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes.
Novak V; Milberg W; Hao Y; Munshi M; Novak P; Galica A; Manor B; Roberson P; Craft S; Abduljalil A
Diabetes Care; 2014; 37(3):751-9. PubMed ID: 24101698
[TBL] [Abstract][Full Text] [Related]
12. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
[TBL] [Abstract][Full Text] [Related]
13. [Targeting the brain through the nose. Effects of intranasally administered insulin].
Brünner YF; Benedict C; Freiherr J
Nervenarzt; 2013 Aug; 84(8):949-54. PubMed ID: 23760596
[TBL] [Abstract][Full Text] [Related]
14. Towards the therapeutic use of intranasal neuropeptide administration in metabolic and cognitive disorders.
Hallschmid M; Benedict C; Schultes B; Perras B; Fehm HL; Kern W; Born J
Regul Pept; 2008 Aug; 149(1-3):79-83. PubMed ID: 18442862
[TBL] [Abstract][Full Text] [Related]
15. Intranasal insulin to improve memory function in humans.
Benedict C; Hallschmid M; Schultes B; Born J; Kern W
Neuroendocrinology; 2007; 86(2):136-42. PubMed ID: 17643054
[TBL] [Abstract][Full Text] [Related]
16. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
[TBL] [Abstract][Full Text] [Related]
17. Awake, long-term intranasal insulin treatment does not affect object memory, odor discrimination, or reversal learning in mice.
Bell GA; Fadool DA
Physiol Behav; 2017 May; 174():104-113. PubMed ID: 28259806
[TBL] [Abstract][Full Text] [Related]
18. Central nervous insulin resistance: a promising target in the treatment of metabolic and cognitive disorders?
Hallschmid M; Schultes B
Diabetologia; 2009 Nov; 52(11):2264-9. PubMed ID: 19705099
[TBL] [Abstract][Full Text] [Related]
19. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
Reger MA; Watson GS; Green PS; Baker LD; Cholerton B; Fishel MA; Plymate SR; Cherrier MM; Schellenberg GD; Frey WH; Craft S
J Alzheimers Dis; 2008 Apr; 13(3):323-31. PubMed ID: 18430999
[TBL] [Abstract][Full Text] [Related]
20. Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.
Galindo-Mendez B; Trevino JA; McGlinchey R; Fortier C; Lioutas V; Novak P; Mantzoros CS; Ngo L; Novak V
Contemp Clin Trials; 2020 Feb; 89():105934. PubMed ID: 31923471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
